{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:24:51Z","timestamp":1781922291905,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Chronic non-bacterial osteomyelitis (CNO) is the most common autoinflammatory bone disease in children and adolescents. This study investigated the progression of CNO lesions during therapy and the potential impact of sarcopenia on disease progression, utilizing routine MRI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective analysis of MRI examinations was conducted on 29 children and adolescents with CNO. CNO lesions were segmented. Sarcopenia was assessed using the total psoas muscle index (PMI) at lumbar vertebral levels L3\/4 and L4\/5. Measurements were taken at four time points during the disease course (T1: baseline, T2\u2013T4: follow-up). Based on the PMI, patients were classified as sarcopenic or non-sarcopenic, and the progression of CNO lesions and the impact of sarcopenia were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 29 patients, aged 1\u201316 years, were included in the study, with 13 males and 16 females. Patients with sarcopenia had a significantly larger mean lesion area (868.95\u2009mm<jats:sup>2<\/jats:sup>, SD\u2009=\u2009684.49) compared to those without sarcopenia (636.11\u2009mm<jats:sup>2<\/jats:sup>, SD\u2009=\u2009832.41); <jats:italic>p<\/jats:italic>\u2009=\u20090.042, <jats:italic>d<\/jats:italic>\u2009=\u20090.4). The comparison between the two patient groups revealed a consistently lower percentage reduction in lesion size for the sarcopenic patients at all time points. Notably, the difference between T1 and T3 was statistically significant (<jats:italic>p<\/jats:italic>\u2009=\u20090.045, <jats:italic>d<\/jats:italic>\u2009=\u20090.82).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The present study indicates that sarcopenia may serve as a negative prognostic factor in the treatment of CNO. Incorporating sarcopenia assessment as an additional parameter in routine whole-body MRI examinations could enhance the evaluation process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Critical relevance statement<\/jats:title>\n            <jats:p>Sarcopenia can be assessed using routine whole-body MRI in patients with CNO and may serve as a negative prognostic factor, potentially enhancing the evaluation process.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key Points<\/jats:title>\n            <jats:p>\n              <jats:list list-type=\"bullet\">\n                <jats:list-item>\n                  <jats:p>Whole-body MRI is crucial for diagnosing and monitoring CNO.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Routine whole-body MRI in CNO patients can also be used to assess sarcopenia as an additional parameter.<\/jats:p>\n                <\/jats:list-item>\n                <jats:list-item>\n                  <jats:p>Sarcopenia may act as a negative prognostic factor in CNO treatment, potentially improving the evaluation process.<\/jats:p>\n                <\/jats:list-item>\n              <\/jats:list>\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s13244-025-02001-w","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:09:02Z","timestamp":1749056942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of sarcopenia on the progression of chronic non-bacterial osteomyelitis"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6421-1400","authenticated-orcid":false,"given":"Daniel","family":"Vogele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"M\u00fcller-Reichart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale\u0161","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henner","family":"Morbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann J.","family":"Girschick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias C.","family":"Schaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinrad","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"2001_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1573396319666221027123723","volume":"20","author":"F Price-Kuehne","year":"2024","unstructured":"Price-Kuehne F, Armon K (2024) Chronic non-bacterial osteomyelitis (CNO) in childhood: a review. Curr Pediatr Rev 20:405\u2013411","journal-title":"Curr Pediatr Rev"},{"key":"2001_CR2","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11914-017-0405-9","volume":"15","author":"SR Hofmann","year":"2017","unstructured":"Hofmann SR, Kapplusch F, Girschick HJ et al (2017) Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment. Curr Osteoporos Rep 15:542\u2013554","journal-title":"Curr Osteoporos Rep"},{"key":"2001_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-017-0216-7","volume":"15","author":"A Taddio","year":"2017","unstructured":"Taddio A, Ferrara G, Insalaco A et al (2017) Dealing with chronic non-bacterial osteomyelitis: a practical approach. Pediatr Rheumatol 15:87","journal-title":"Pediatr Rheumatol"},{"key":"2001_CR4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/rheumatology\/key058","volume":"57","author":"H Girschick","year":"2018","unstructured":"Girschick H, Finetti M, Orlando F et al (2018) The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology 57:1203\u20131211","journal-title":"Rheumatology"},{"key":"2001_CR5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1651-2227.2011.02205.x","volume":"100","author":"FA Jansson","year":"2011","unstructured":"Jansson FA, Grote V (2011) Nonbacterial osteitis in children: data of a German Incidence Surveillance Study. Acta Paediatr 100:1150\u20131157","journal-title":"Acta Paediatr"},{"key":"2001_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/ard.2004.023838","volume":"64","author":"HJ Girschick","year":"2005","unstructured":"Girschick HJ, Raab P, Surbaum S et al (2005) Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis 64:279\u2013285","journal-title":"Ann Rheum Dis"},{"key":"2001_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11926-020-00928-1","volume":"22","author":"CM Hedrich","year":"2020","unstructured":"Hedrich CM, Morbach H, Reiser C, Girschick HJ (2020) New insights into adult and paediatric chronic non-bacterial osteomyelitis CNO. Curr Rheumatol Rep 22:52","journal-title":"Curr Rheumatol Rep"},{"key":"2001_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1546-0096-11-47","volume":"11","author":"CM Hedrich","year":"2013","unstructured":"Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ (2013) Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 11:47","journal-title":"Pediatr Rheumatol Online J"},{"key":"2001_CR9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/art.39013","volume":"67","author":"J Wipff","year":"2015","unstructured":"Wipff J, Costantino F, Lemelle I et al (2015) A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol 67:1128\u20131137","journal-title":"Arthritis Rheumatol"},{"key":"2001_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00530-4","volume":"19","author":"D O'leary","year":"2021","unstructured":"O'leary D, Wilson AG, MacDermott EJ, Lowry C, Killeen OG (2021) Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort. Pediatr Rheumatol 19:45","journal-title":"Pediatr Rheumatol"},{"key":"2001_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/kel190","volume":"46","author":"A Jansson","year":"2007","unstructured":"Jansson A, Renner ED, Ramser J et al (2007) Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology 46:154\u2013160","journal-title":"Rheumatology"},{"key":"2001_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2004-835364","volume":"8","author":"GA Jurik","year":"2004","unstructured":"Jurik GA (2004) Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol 8:243\u2013253","journal-title":"Semin Musculoskelet Radiol"},{"key":"2001_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/01241398-200207000-00016","volume":"22","author":"CM Duffy","year":"2002","unstructured":"Duffy CM, Lam PY, Ditchfield M, Allen R, Graham HK (2002) Chronic recurrent multifocal osteomyelitis: review of orthopaedic complications at maturity. J Pediatr Orthop 22:501\u2013505","journal-title":"J Pediatr Orthop"},{"key":"2001_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13244-021-01059-6","volume":"12","author":"MC Schaal","year":"2021","unstructured":"Schaal MC, Gendler L, Ammann B et al (2021) Imaging in non-bacterial osteomyelitis in children and adolescents: diagnosis, differential diagnosis and follow-up\u2014an educational review based on a literature survey and own clinical experiences. Insights Imaging 12:113","journal-title":"Insights Imaging"},{"key":"2001_CR15","first-page":"578","volume":"30","author":"H Morbach","year":"2012","unstructured":"Morbach H, Schneider P, Schwarz T et al (2012) Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents. Clin Exp Rheumatol 30:578\u2013582","journal-title":"Clin Exp Rheumatol"},{"key":"2001_CR16","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/ar2992","volume":"12","author":"C Beck","year":"2010","unstructured":"Beck C, Morbach H, Beer M et al (2010) Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther 12:R74","journal-title":"Arthritis Res Ther"},{"key":"2001_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bone.2005.07.009","volume":"38","author":"PJ Ferguson","year":"2006","unstructured":"Ferguson PJ, Bing X, Vasef MA et al (2006) A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 38:41\u201347","journal-title":"Bone"},{"key":"2001_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13075-021-02658-w","volume":"23","author":"C Reiser","year":"2021","unstructured":"Reiser C, Klotsche J, Hospach A et al (2021) First-year follow-up of children with chronic nonbacterial osteomyelitis\u2014an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018. Arthritis Res Ther 23:281","journal-title":"Arthritis Res Ther"},{"key":"2001_CR19","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3390\/diagnostics11122314","volume":"11","author":"A Faron","year":"2021","unstructured":"Faron A, Opheys NS, Nowak S et al (2021) Deep learning-based body composition analysis predicts outcome in melanoma patients treated with immune checkpoint inhibitors. Diagnostics (Basel) 11:2314","journal-title":"Diagnostics (Basel)"},{"key":"2001_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13075-023-03195-4","volume":"25","author":"C Reiser","year":"2023","unstructured":"Reiser C, Klotsche J, Hospach T et al (2023) Long-term follow-up of children with chronic non-bacterial osteomyelitis\u2014assessment of disease activity, risk factors, and outcome. Arthritis Res Ther 25:228","journal-title":"Arthritis Res Ther"},{"key":"2001_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/a-1990-0201","volume":"195","author":"D Vogele","year":"2023","unstructured":"Vogele D, Otto S, Sollmann N et al (2023) Sarcopenia\u2014definition, radiological diagnosis, clinical significance. Rofo 195:393\u2013405","journal-title":"Rofo"},{"key":"2001_CR22","doi-asserted-by":"publisher","first-page":"718184","DOI":"10.3389\/fsurg.2021.718184","volume":"8","author":"A Ritz","year":"2021","unstructured":"Ritz A, Froeba-Pohl A, Kolorz J et al (2021) Total psoas muscle area as a marker for sarcopenia is related to outcome in children with neuroblastoma. Front Surg 8:718184","journal-title":"Front Surg"},{"key":"2001_CR23","doi-asserted-by":"publisher","first-page":"e28862","DOI":"10.1002\/pbc.28862","volume":"68","author":"A Ritz","year":"2021","unstructured":"Ritz A, Kolorz J, Hubertus J et al (2021) Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma. Pediatr Blood Cancer 68:e28862","journal-title":"Pediatr Blood Cancer"},{"key":"2001_CR24","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.asjsur.2024.03.009","volume":"47","author":"M-J Bang","year":"2024","unstructured":"Bang M-J, Lee S, Lee JW, Kim W, Sung KW, Seo JM (2024) Sarcopenia with decreased total psoas muscle area in children with high-risk neuroblastoma. Asia J Surg 47:2584\u20132588","journal-title":"Asia J Surg"},{"key":"2001_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jcsm.12514","volume":"11","author":"E Lurz","year":"2020","unstructured":"Lurz E, Patel H, Lebovic G et al (2020) Paediatric reference values for total psoas muscle area. J Cachexia Sarcopenia Muscle 11:405\u2013414","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2001_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-021-00282-5","volume":"11","author":"A Dhaliwal","year":"2021","unstructured":"Dhaliwal A, Williams FR, Quinlan JI et al (2021) Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study. Skelet Muscle 11:27","journal-title":"Skelet Muscle"},{"key":"2001_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1097\/MPG.0000000000003091","volume":"72","author":"L Atlan","year":"2021","unstructured":"Atlan L, Cohen S, Shiran S, Sira LB, Pratt LT, Yerushalmy-Feler A (2021) Sarcopenia is a predictor for adverse clinical outcome in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 72:883\u2013888","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2001_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.clnesp.2023.08.009","volume":"57","author":"B Aljilani","year":"2023","unstructured":"Aljilani B, Tsintzas K, Jacques M, Radford S, Moran GW (2023) Systematic review: sarcopenia in paediatric inflammatory bowel disease. Clin Nutr ESPEN 57:647\u2013654","journal-title":"Clin Nutr ESPEN"},{"key":"2001_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37229-3","volume":"13","author":"LA Da Costa Teixeira","year":"2023","unstructured":"Da Costa Teixeira LA, Avelar N, Peixoto M et al (2023) Inflammatory biomarkers at different stages of Sarcopenia in older women. Sci Rep 13:10367","journal-title":"Sci Rep"},{"key":"2001_CR30","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.clnu.2016.02.002","volume":"35","author":"G Bahat","year":"2016","unstructured":"Bahat G, Tufan A, Tufan F et al (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 35:1557\u20131563","journal-title":"Clin Nutr"},{"key":"2001_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.clnu.2024.06.024","volume":"43","author":"T Inoue","year":"2024","unstructured":"Inoue T, Wakabayashi H, Kawase F et al (2024) Diagnostic criteria, prevalence, and clinical outcomes of pediatric sarcopenia: a scoping review. Clin Nutr 43:1825\u20131843","journal-title":"Clin Nutr"},{"key":"2001_CR32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/MCO.0000000000000969","volume":"26","author":"DR Mager","year":"2023","unstructured":"Mager DR, Hager A, Gilmour S (2023) Challenges and physiological implications of sarcopenia in children and youth in health and disease. Curr Opin Clin Nutr Metab Care 26:528\u2013533","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2001_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16\u201331","journal-title":"Age Ageing"},{"key":"2001_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jss.2019.01.064","volume":"239","author":"AD Isiklar","year":"2019","unstructured":"Isiklar AD, Safer U, Safer VB (2019) The influence of sarcopenia on high-risk neuroblastoma. J Surg Res 239:173","journal-title":"J Surg Res"},{"key":"2001_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/jpen.1681","volume":"44","author":"PH Ooi","year":"2020","unstructured":"Ooi PH, Thompson-Hodgetts S, Pritchard-Wiart L, Gilmour SM, Mager DR (2020) Pediatric aarcopenia: a paradigm in the overall definition of malnutrition in children? JPEN J Parenter Enter Nutr 44:407\u2013418","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"2001_CR36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpeds.2017.10.066","volume":"194","author":"E Lurz","year":"2018","unstructured":"Lurz E, Quammie C, Englesbe M et al (2018) Frailty in children with liver disease: a prospective multicenter study. J Pediatr 194:109\u2013115.e4","journal-title":"J Pediatr"},{"key":"2001_CR37","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/jcsm.13049","volume":"13","author":"K Marunowski","year":"2022","unstructured":"Marunowski K, \u015awi\u0119to\u0144 D, Bzyl W et al (2022) Reference values for MRI\u2010derived psoas and paraspinal muscles and macroscopic fat infiltrations in paraspinal muscles in children. J Cachexia Sarcopenia Muscle 13:2515\u20132524","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2001_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.clnu.2023.02.022","volume":"42","author":"W Kudo","year":"2023","unstructured":"Kudo W, Terui K, Hattori S et al (2023) Establishment and validation of reference values for abdominal skeletal muscle compartments in children. Clin Nutr 42:653\u2013660","journal-title":"Clin Nutr"},{"key":"2001_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41430-021-01016-y","volume":"76","author":"S Triarico","year":"2022","unstructured":"Triarico S, Rinninella E, Mele MC, Cintoni M, Attin\u00e0 G, Ruggiero A (2022) Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice. Eur J Clin Nutr 76:783\u2013788","journal-title":"Eur J Clin Nutr"},{"key":"2001_CR40","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/diagnostics14020198","volume":"14","author":"D Vogele","year":"2024","unstructured":"Vogele D, Mueller T, Wolf D et al (2024) Applicability of the CT radiomics of skeletal muscle and machine learning for the detection of sarcopenia and prognostic assessment of disease progression in patients with gastric and esophageal tumors. Diagnostics (Basel) 14:198","journal-title":"Diagnostics (Basel)"},{"key":"2001_CR41","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1007\/s12094-024-03421-8","volume":"26","author":"Y Su","year":"2024","unstructured":"Su Y, Wu Y, Li C, Sun T, Li Y, Wang Z (2024) Sarcopenia among treated cancer patients before and after neoadjuvant chemotherapy: a systematic review and meta-analysis of high-quality studies. Clin Transl Oncol 26:1844\u20131855","journal-title":"Clin Transl Oncol"},{"key":"2001_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2214\/AJR.21.27239","volume":"219","author":"E Somasundaram","year":"2022","unstructured":"Somasundaram E, Castiglione JA, Brady SL, Trout AT (2022) Defining normal ranges of skeletal muscle area and skeletal muscle index in children on CT using an automated deep learning pipeline: implications for sarcopenia diagnosis. AJR Am J Roentgenol 219:326\u2013336","journal-title":"AJR Am J Roentgenol"},{"key":"2001_CR43","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.clnu.2019.04.012","volume":"38","author":"CE Orsso","year":"2019","unstructured":"Orsso CE, Tibaes J, Oliveira C et al (2019) Low muscle mass and strength in pediatrics patients: Why should we care? Clin Nutr 38:2002\u20132015","journal-title":"Clin Nutr"},{"key":"2001_CR44","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/jcsm.12221","volume":"8","author":"VE Baracos","year":"2017","unstructured":"Baracos VE (2017) Psoas as a sentinel muscle for sarcopenia: a flawed premise. J Cachexia Sarcopenia Muscle 8:527\u2013528","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2001_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/jcsm.12180","volume":"8","author":"IJG Rutten","year":"2017","unstructured":"Rutten IJG, Ubachs J, Kruitwagen R, Beets-Tan R, Olde Damink S, Van Gorp T (2017) Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer. J Cachexia Sarcopenia Muscle 8:630\u2013638","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2001_CR46","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.3390\/nu15173838","volume":"15","author":"P Blagec","year":"2023","unstructured":"Blagec P, Sara S, Tripalo Bato\u0161 A et al (2023) Magnetic resonance imaging can be used to assess sarcopenia in children with newly diagnosed crohn\u2019s disease. Nutrients 15:3838","journal-title":"Nutrients"},{"key":"2001_CR47","doi-asserted-by":"publisher","first-page":"e14256","DOI":"10.1111\/petr.14256","volume":"26","author":"VK Raghu","year":"2022","unstructured":"Raghu VK, Sico R, Rudolph JA, Mazariegos GV, Squires J, Squires JE (2022) Sarcopenia prevalence in pediatric intestinal transplant recipients: implications on post-transplant outcomes. Pediatr Transpl 26:e14256","journal-title":"Pediatr Transpl"},{"key":"2001_CR48","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/lt.25985","volume":"27","author":"JP Woolfson","year":"2021","unstructured":"Woolfson JP, Perez M, Chavhan GB et al (2021) Sarcopenia in children with end\u2010stage liver disease on the transplant waiting list. Liver Transplant 27:641\u2013651","journal-title":"Liver Transplant"},{"key":"2001_CR49","doi-asserted-by":"publisher","first-page":"e13950","DOI":"10.1111\/petr.13950","volume":"25","author":"M Takeda","year":"2021","unstructured":"Takeda M, Sakamoto S, Uchida H et al (2021) Impact of sarcopenia in infants with liver transplantation for biliary atresia. Pediatr Transpl 25:e13950","journal-title":"Pediatr Transpl"},{"key":"2001_CR50","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1111\/ajt.13832","volume":"16","author":"P Tandon","year":"2016","unstructured":"Tandon P, Mourtzakis M, Low G et al (2016) Comparing the variability between measurements for sarcopenia using magnetic resonance imaging and computed tomography imaging. Am J Transplant 16:2766\u20132767","journal-title":"Am J Transplant"},{"key":"2001_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.clnu.2021.11.010","volume":"41","author":"IALP Van Beijsterveldt","year":"2022","unstructured":"Van Beijsterveldt IALP, van der Steen M, de Fluiter KS, Spaans S, Hokken-Koelega A (2022) Body composition and bone mineral density by dual energy X-ray absorptiometry: reference values for young children. Clin Nutr 41:71\u201379","journal-title":"Clin Nutr"},{"key":"2001_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jbmt.2017.04.010","volume":"22","author":"JA Chula de Castro","year":"2018","unstructured":"Chula de Castro JA, de Lima TR, Silva DAS (2018) Body composition estimation in children and adolescents by bioelectrical impedance analysis: a systematic review. J Bodyw Mov Ther 22:134\u2013146","journal-title":"J Bodyw Mov Ther"},{"key":"2001_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00657-4","volume":"20","author":"L Ma","year":"2022","unstructured":"Ma L, Liu H, Tang H et al (2022) Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series. Pediatr Rheumatol 20:1","journal-title":"Pediatr Rheumatol"},{"key":"2001_CR54","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/msc.1823","volume":"21","author":"MP Smith","year":"2023","unstructured":"Smith MP, Tracy B, Soncrant J, Young JL, Rhon DI, Cook CE (2023) What factors do physical therapists consider when determining patient prognosis: a mixed methods study. Musculoskelet Care 21:1412\u20131420","journal-title":"Musculoskelet Care"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02001-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-02001-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02001-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:03:15Z","timestamp":1749060195000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-02001-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2001"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-02001-w","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the University of Ulm (no. 349\/21) and the University of W\u00fcrzburg (no. 68\/03).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent from the patients\u2019 parents was required for participation in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}